Drug Database
Back to search

Netherlands· NL-bfa18a9b7be9

Rapilysin 10 U, poeder voor injectievloeistof 10 U

A reteplase product containing reteplase, registered in Netherlands by Actavis Group PTC ehf. The same ATC class is registered in 7 of our 19 countries.

ATC B01AD07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedRapilysin 10 U, poeder voor injectiev…ATCB01AD07REGISTER NO.NL-bfa18a9b7be9PACKS LISTED1CHECKEDJune 16, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about reteplaseAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Reteplase is registered in 7 of 19 countries.

Countries holding a registration under ATC B01AD07 (reteplase), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose
Search reteplase products by name

Reteplase · ATC B01AD07

7 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
RETEPLASE
Manufacturer
Actavis Group PTC ehf
Country
Netherlands (NL)
ATC code
B01AD07
ATC class
Reteplase
Defined daily dose
20 E, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
June 16, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/96/018

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

143 interactions on record for reteplase.

Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check reteplase against other medicinesHow interaction checks work

Reteplase · interactions on record

143 records

  • 49 severe
  • 94 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Reteplase in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All reteplase products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1267cf51-5185-4f44-b25b-abc0bf9fb50a
GET /v1/drugs/1267cf51-5185-4f44-b25b-abc0bf9fb50a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/rapilysin-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Reteplase",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70012",
  "excipients": [
    "DIKALIUMWATERSTOFFOSFAAT 0-WATER (E 340)",
    "FOSFORZUUR (E 338)",
    "POLYSORBAAT 80 (E 433)",
    "SACCHAROSE",
    "TRANEXAMINEZUUR",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "RETEPLASE"
  ],
  "leaflet_url": null,
  "authorised_at": "1996/08/29",
  "procedure_number": "EMEA/H/C/000105",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/96/018",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about reteplase.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console